$1.47
0.032.08%
At close: -
$1.47
0.000.00%
After Hours: 4:02 PM EDT
Climb Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Climb Bio using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q2 | 2023-08-10 | $-0.19 | $-0.16 | -18.8 % |
Q1 | 2023-05-11 | $-0.84 | $-0.25 | -236.0 % |
Q4 | 2023-03-06 | $-0.29 | $-0.38 | 23.7 % |
Q3 | 2022-11-14 | $-0.37 | $-0.43 | 14.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Climb Bio (CLYM) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.13, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.